{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:19:08Z","timestamp":1790619548228,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175023"],"award-info":[{"award-number":["175023"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/ijcp.13005","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T14:36:39Z","timestamp":1504535799000},"page":"e13005","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study"],"prefix":"10.1155","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-7965","authenticated-orcid":false,"given":"Milena","family":"Kova\u010devi\u0107","sequence":"first","affiliation":[{"name":"Department of Pharmacokinetics and Clinical Pharmacy; Faculty of Pharmacy; University of Belgrade; Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vezmar Kova\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Clinical Pharmacy; Faculty of Pharmacy; University of Belgrade; Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislava","family":"Miljkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Clinical Pharmacy; Faculty of Pharmacy; University of Belgrade; Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Radovanovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; University Clinical Hospital Center Be\u017eanijska Kosa; University of Belgrade; Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Predrag","family":"Stevanovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; University Clinical Hospital Center Be\u017eanijska Kosa; University of Belgrade; Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"10.1111\/ijcp.13005-BIB0001|ijcp13005-cit-0001","unstructured":"World Health Organization Global status report on noncommunicable diseases 2014 http:\/\/www.who.int\/nmh\/publications\/ncd-status-report-2014\/en\/"},{"key":"10.1111\/ijcp.13005-BIB0002|ijcp13005-cit-0002","first-page":"e86","article-title":"Medical care costs among patients with established cardiovascular disease","volume":"16","author":"Nichols","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1111\/ijcp.13005-BIB0003|ijcp13005-cit-0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2298\/VSP1402137L","article-title":"Economic burden of cardiovascular diseases in Serbia","volume":"71","author":"Lakic","year":"2014","journal-title":"Vojnosanit Pregl"},{"key":"10.1111\/ijcp.13005-BIB0004|ijcp13005-cit-0004","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe 2015: epidemiological update","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.13005-BIB0005|ijcp13005-cit-0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00228-004-0830-4","article-title":"The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals","volume":"60","author":"Blix","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0006|ijcp13005-cit-0006","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5414\/CPP45643","article-title":"Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002","volume":"45","author":"Haider","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/ijcp.13005-BIB0007|ijcp13005-cit-0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","article-title":"The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010","volume":"13","author":"Guthrie","year":"2015","journal-title":"BMC Med"},{"key":"10.1111\/ijcp.13005-BIB0008|ijcp13005-cit-0008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.amjopharm.2011.10.004","article-title":"Potentially harmful drug-drug interactions in the elderly: a review","volume":"9","author":"Hines","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1111\/ijcp.13005-BIB0009|ijcp13005-cit-0009","volume-title":"Stockley's Drug Interactions","author":"Preston","year":"2013","edition":"10"},{"key":"10.1111\/ijcp.13005-BIB0010|ijcp13005-cit-0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18433\/J35C7Z","article-title":"Drug-drug interactions associated with length of stay and cost of hospitalization","volume":"12","author":"Moura","year":"2009","journal-title":"J Pharm Pharm Sci"},{"key":"10.1111\/ijcp.13005-BIB0011|ijcp13005-cit-0011","first-page":"526","article-title":"Impact of pharmacists\u2019 intervention on identification and management of drug-drug interactions in an intensive care setting","volume":"53","author":"Hasan","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1111\/ijcp.13005-BIB0012|ijcp13005-cit-0012","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00002018-200730050-00003","article-title":"Drug-related problems in hospitals: a review of the recent literature","volume":"30","author":"Krahenbuhl-Melcher","year":"2007","journal-title":"Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0013|ijcp13005-cit-0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/14740338.2012.631910","article-title":"Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions","volume":"11","author":"Magro","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0014|ijcp13005-cit-0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40264-014-0262-8","article-title":"Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support","volume":"38","author":"Scheife","year":"2015","journal-title":"Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0015|ijcp13005-cit-0015","volume-title":"To err is human: building a safer health system","author":"Kohn","year":"1999"},{"key":"10.1111\/ijcp.13005-BIB0016|ijcp13005-cit-0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/17512433.2014.910111","article-title":"Understanding and preventing drug-drug and drug-gene interactions","volume":"7","author":"Tannenbaum","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0017|ijcp13005-cit-0017","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-010-1778-8","article-title":"Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system","volume":"36","author":"Bertsche","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1111\/ijcp.13005-BIB0018|ijcp13005-cit-0018","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00508-008-1089-z","article-title":"Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria","volume":"120","author":"Schuler","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"10.1111\/ijcp.13005-BIB0019|ijcp13005-cit-0019","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s11096-012-9697-0","article-title":"Prevalence of drug interactions in hospital healthcare","volume":"34","author":"Espinosa-Bosch","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1111\/ijcp.13005-BIB0020|ijcp13005-cit-0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCOUTCOMES.108.846493","article-title":"Iatrogenic adverse events in the coronary care unit","volume":"2","author":"Rahim","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1111\/ijcp.13005-BIB0021|ijcp13005-cit-0021","first-page":"9","article-title":"Patient risk factors for developing a drug-related problem in a cardiology ward","volume":"11","author":"Urbina","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/ijcp.13005-BIB0022|ijcp13005-cit-0022","doi-asserted-by":"crossref","first-page":"920","DOI":"10.5114\/aoms.2014.46212","article-title":"Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease","volume":"10","author":"Roblek","year":"2014","journal-title":"Arch Med Sci"},{"key":"10.1111\/ijcp.13005-BIB0023|ijcp13005-cit-0023","unstructured":"Charlson ME Foley WT Charlson comorbidity index, chart review version https:\/\/www.rtog.org\/LinkClick.aspx?fileticket=8o6FpyC8s9w%3D***%5band%5d***tabid=290"},{"key":"10.1111\/ijcp.13005-BIB0024|ijcp13005-cit-0024","unstructured":"Lexicomp Online \u00ae , LexiInteract Hudson, Ohio Lexi-Comp, Inc"},{"key":"10.1111\/ijcp.13005-BIB0025|ijcp13005-cit-0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","article-title":"Drug-drug interaction software in clinical practice: a systematic review","volume":"71","author":"Roblek","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0026|ijcp13005-cit-0026","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11096-008-9191-x","article-title":"Evaluation of frequently used drug interaction screening programs","volume":"30","author":"Vonbach","year":"2008","journal-title":"Pharm World Sci"},{"key":"10.1111\/ijcp.13005-BIB0027|ijcp13005-cit-0027","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11096-010-9445-2","article-title":"Evaluation of three brands of drug interaction software for use in intensive care units","volume":"32","author":"Reis","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1111\/ijcp.13005-BIB0028|ijcp13005-cit-0028","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2015.05.012","article-title":"Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist","volume":"26","author":"Guignard","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1111\/ijcp.13005-BIB0029|ijcp13005-cit-0029","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/11592030-000000000-00000","article-title":"Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands","volume":"34","author":"Dequito","year":"2011","journal-title":"Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0030|ijcp13005-cit-0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/phar.1395","article-title":"Analysis of potential drug-drug interactions in medical intensive care unit patients","volume":"34","author":"Uijtendaal","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ijcp.13005-BIB0031|ijcp13005-cit-0031","first-page":"427","article-title":"Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital","volume":"9","author":"Cruciol-Souza","year":"2006","journal-title":"J Pharm Pharm Sci"},{"key":"10.1111\/ijcp.13005-BIB0032|ijcp13005-cit-0032","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00228-002-0557-z","article-title":"Potential drug-drug interactions in the medication of medical patients at hospital discharge","volume":"58","author":"Egger","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0033|ijcp13005-cit-0033","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/bcp.12600","article-title":"Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review","volume":"80","author":"Saedder","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0034|ijcp13005-cit-0034","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejim.2007.12.002","article-title":"Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine","volume":"19","author":"Vonbach","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1111\/ijcp.13005-BIB0035|ijcp13005-cit-0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/11532340-000000000-00000","article-title":"Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US","volume":"33","author":"Smithburger","year":"2010","journal-title":"Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0036|ijcp13005-cit-0036","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejim.2014.10.001","article-title":"Understanding adverse drug reactions in older adults through drug-drug interactions","volume":"25","author":"Marengoni","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1111\/ijcp.13005-BIB0037|ijcp13005-cit-0037","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A systematic review of hospitalization resulting from medicine-related problems in adult patients","volume":"78","author":"Al Hamid","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0038|ijcp13005-cit-0038","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis","volume":"23","author":"Dechanont","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/ijcp.13005-BIB0039|ijcp13005-cit-0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00228-007-0422-1","article-title":"The clinical implications of ageing for rational drug therapy","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/ijcp.13005-BIB0040|ijcp13005-cit-0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cpcardiol.2008.08.002","article-title":"Adverse drug reactions in patients with cardiovascular disease","volume":"33","author":"Faulx","year":"2008","journal-title":"Curr Probl Cardiol"},{"key":"10.1111\/ijcp.13005-BIB0041|ijcp13005-cit-0041","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jcrc.2010.04.014","article-title":"Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients","volume":"26","author":"Rivkin","year":"2011","journal-title":"J Crit Care"},{"key":"10.1111\/ijcp.13005-BIB0042|ijcp13005-cit-0042","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archinte.166.9.955","article-title":"Clinical pharmacists and inpatient medical care: a systematic review","volume":"166","author":"Kaboli","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.13005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.13005\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:10:58Z","timestamp":1643350258000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.13005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.13005","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,4]]}}}